A barrier layer and corresponding method of making provide anti-inflammatory, non-inflammatory, and anti-adhesion functionality for a medical device implantable in a patient. The barrier layer can be combined with a medical device structure to provide anti-adhesion characteristics, in addition to improved healing, non-inflammatory, and anti-inflammatory response. The barrier layer is generally formed of a naturally occurring oil, or an oil composition formed in part of a naturally occurring oil, that is at least partially cured forming a cross-linked gel. In addition, the oil composition can include a therapeutic agent component, such as a drug or other bioactive agent.

A closing dressing bolster and assembly for use with a system for treating a linear wound on a patient includes a bolster body formed from a flexible closing bolster material having closing members that are operable to develop an inward closing force when the closing dressing bolster is placed under reduced pressure. In one aspect, when the closing dressing bolster is under reduced pressure, the system, dressing, or assembly develops an inward force realized at the linear wound and a compression force. A wicking-material holder and wicking material may be used as well. The member components may all be see-through to allow visual inspection of the wound without requiring removal of the dressing.

A curable composition for use in wound care comprising, apportioned between at least one Part A and at least one Part B: one or more alkenyl-group containing polymers (i) having at least one alkenyl group or moiety per molecule, one or more SiH-containing polymers (ii) having at least one Si—H unit per molecule; and a catalyst (iii) for curing by addition of alkenyl-containing polymer (i) to SiH-containing polymer (ii), Part A and Part B independently having viscosity at 23° C. in the range 5-300 Pa.Math.s, preferably 10-100 Pa.Math.s, at a shearing rate of 10 s.sup.−1, and when combined in one Part having cure time at 23° C. in the range from 0.5 min to 25 min, wherein when dispensed into a location about a wound dressing, said wound dressing overlying a wound site and skin thereabout, said dispensing being so as to intimately contact and overlie an edge of said dressing and skin about said edge, the composition cures in contact with said edge and skin at 32° C. to an elastomer exhibiting zero or low tack at a time in the range from 0.5 to less than 30 minutes, apparatus for use with said composition comprising dispensing apparatus or wound dressing, a kit comprising the same, and methods of dispensing and curing the same and of using the same in sealing a wound dressing and in treating a wound site of a human in need thereof.

Systems, methods, and apparatuses for treating a tissue site with reduced pressure are described. The system includes a manifold configured to be placed adjacent the tissue site, and a sealing member configured to be placed over the tissue site and the manifold. The system also includes a reduced-pressure source fluidly coupled to the manifold through the sealing member. The system further includes a pouch having an upstream layer having a first thickness, a downstream layer having a second thickness, and an absorbent member enclosed between the upstream layer and the downstream layer. The second thickness is greater than the first thickness. The upstream layer may have a hydrophilic side adjacent the absorbent member, and the downstream layer may have a hydrophobic side adjacent the absorbent member.

A protective device configured in accordance with a particular embodiment includes a cover including a first region that extends over a vulnerable site on a patient and a second region that extends over an area on the patient peripheral to the vulnerable site. The first region of the cover is at least generally impermeable to liquid water. The device further includes an adhesive film and a liquid-absorbing element. The adhesive film is configured to form an adhesive bond between the second region of the cover and the patient. The bond has an inner edge portion positioned toward the vulnerable site and an outer edge portion positioned away from the vulnerable site. The liquid-absorbing element is configured to absorb liquid contamination at the outer edge portion of the bond and/or liquid contamination approaching the outer edge portion of the bond when the cover is operably positioned on the patient.

Provided are: an acrylic adhesive sheet having a porous structure including a plurality of pores and having a water vapor transmission rate of 2,000 g/m.sup.2.Math.24 h to 3,500 g/m.sup.2.Math.24 h at 24° C. and 25% RH, and a porosity of 10% to 60%; and a medical adhesive tape including the same.

A medical dressing is provided. The dressing has a central portion and a border portion, and comprises a backing layer, an adhesive body contact layer and a pad arranged in the central portion between the backing layer and the adhesive body contact layer. The pad is symmetric about a longitudinal center line and the dressing comprises a lobed portion on each side of the center line. The medical dressing comprises a gripping tab which is coplanar with the border portion and which projects outwardly from the border portion. The medical dressing may be used for pressure ulcer prevention, such as at the sacrum region of a human body.

A wound exposure device is disclosed that can be applied to a patient having excessive or redundant tissue (i.e., a panniculus) to retain the excessive or redundant tissue away from (off of) a wound to allow air so that the excessive or redundant tissue will not cover the wound while the wound is healing. The wound exposure device is wearable and highly conformable when applied to a patient to support/hold/retract redundant and/or excessive tissue off or away from a wound site for extended periods of time. The ability to wear the wound exposure device for extended periods of time facilitates better healing of wounds which would otherwise be covered by the redundant flesh.

A wound exposure device is disclosed that can be applied to a patient having excessive or redundant tissue (i.e., a panniculus) to retain the excessive or redundant tissue away from (off of) a wound to allow air so that the excessive or redundant tissue will not cover the wound while the wound is healing. The wound exposure device is wearable and highly conformable when applied to a patient to support/hold/retract redundant and/or excessive tissue off or away from a wound site for extended periods of time. The ability to wear the wound exposure device for extended periods of time facilitates better healing of wounds which would otherwise be covered by the redundant flesh.

A bandage system lances a skin tag from a person's body and thereafter projects the wound created. The system has a base layer that is adhesively attached to the person such that the skin tag passes through an opening of the base layer. A cutter is located atop the base layer and uses a pair of blades that are squeezed together to cut the skin tag protruding through the opening. After cutting, a protective layer is adhered to the base layer such that a medicine laden absorbent pad on the protective layer overlays the opening on the base layer absorbing any blood from the wound and applying the medicine to the wound. Thereafter, the system is worn as a typical bandage.